Das Endometriumkarzinom ist in Deutschland mit über 11.000 Neuerkrankungen pro Jahr das vierthäufigste Malignom der Frau. Es hat einen Anteil von 5,1 % an bösartigen Neuerkrankungen der Frau. Der Altersgipfel liegt zwischen 65 und 85 Jahren, mit ansteigender Tendenz angesichts der demographischen Entwicklung wie auch einer Zunahme der Adipositas. Die relative 5-Jahres-Überlebensrate liegt in Deutschland bei ca. 79 % [1].
Literatur
GEKID/RKI (2012) Krebs in Deutschland 2007/2008. Endometriumkarzinom. RKI, Berlin
Sobin LH, Gospodarowicz MK, Wittekind C (Hrsg) (2009) TNM classification of malignant tumors. Wiley-Blackwell, Oxford
Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105: 109
Fanning J, Alvarez PM, Tsukada Y, Piver MS (1991) Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol Oncol 40: 46–47
Sartori E, Gadducci A, Landoni F et al (2001) Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11: 430–437
Lewin SN, Herzog TJ, Barrena Medel NI, et al (2010) Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 116: 1141–1149
Straughn JM Jr, Huh WK, Kelly FJ et al (2002) Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84: 194–200
Chan JK, Wu H, Cheung MK, et al (2007) The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 106: 282–288
Abu-Rustum NR, Zhou Q, Iasonos A, et al (2011) The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 21: 511–516
Creasman WT, Morrow CP, Bundy BN, et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl): 2035–2041
Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. in der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. sowie in der Deutschen Krebsgesellschaft eV. Interdisziplinäre S2K-Leitlinie für die Diagnostik und Therapie des Endometriumkarzinoms. (Registernummer 032–034). http: //www.awmf.org/leitlinien/detail/ll/032-034.html. Aktualisierte Empfehlungen (2013). http://www.ago-online.de/fileadmin/downloads/leitlinien/uterus/empfehlungen_diagnostik_therapie_EC.pdf
Barton DP, Naik R, Herod J (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study. Int J Gynecol Cancer 19: 1465
Benedetti Panici P, Basile S, Maneschi F, et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100: 1707–1716
Smith DC, Macdonald OK, Lee CM, Gaffney DK (2008) Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis. Int J Gynecol Cancer 18: 255–261
Todo Y, Kato H, Kaneuchi M, et al (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721): 1165–1172
Zorlu CG, Simsek T, Ari ES (2005) Laparoscopy or laparotomy for the management of endometrial cancer. JSLS 9: 442–446
Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12: 130–136
Fram KM (2002) Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in stage I endometrial cancer. Int J Gynecol Cancer 12: 57–61
Malzoni M, Tinelli R, Cosentino F et al (2009) Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study. Gynecol Oncol 112: 126–133
Zullo F, Palomba S, Falbo A et al (2009) Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial. Am J Obstet Gynecol 200: 296.e1–e9
Cohn DE, Woeste EM, Cacchio S, et al (2007) Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 109: 1062–1067
Nout RA, Putter H, Jurgenliemk-Schulz IM, et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27: 3547–3556
Keys HM, Roberts JA, Brunetto VL, et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92: 744–751
Randall ME, Filiaci VL, Muss H et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36–44
Susumu N, Sagae S, Udagawa Y et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108: 226–233
Greven K, Winter K, Underhill K et al (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103: 155–159
Hogberg T (2008) Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol (R Coll Radiol) 20: 463–469
Author information
Authors and Affiliations
Corresponding author
Additional information
Einhaltung der ethischen Richtlinien
Interessenkonflikt. P. Hillemanns, H. Hertel und T.-W. Park-Simon geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Hillemanns, P. Neue TNM-Klassifikation beim Endometriumkarzinom. best practice onkologie 8, 22–27 (2013). https://doi.org/10.1007/s11654-013-0102-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11654-013-0102-9